Journal article
Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies
Abstract
In December 2020, an interim recommendation for the use of Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years was made under Food and Drug Administration's Emergency Use Authorization. In preparation for Biologics License Application approval, we conducted a systematic review and meta-analysis to inform the U.S. Centers for Disease Control and Prevention's Advisory Committee for Immunization Practice's (ACIP) decision-making for a …
Authors
Wallace M; Collins JP; Moline H; Plumb ID; Godfrey M; Morgan RL; Campos-Outcalt D; Oliver SE; Dooling K; Gargano JW
Journal
PLOS ONE, Vol. 17, No. 12,
Publisher
Public Library of Science (PLoS)
DOI
10.1371/journal.pone.0278624
ISSN
1932-6203